1. Home
  2. ZKH vs ZVRA Comparison

ZKH vs ZVRA Comparison

Compare ZKH & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZKH

ZKH Group Limited

HOLD

Current Price

$3.14

Market Cap

484.8M

Sector

N/A

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$10.70

Market Cap

472.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZKH
ZVRA
Founded
1998
2006
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
484.8M
472.9M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
ZKH
ZVRA
Price
$3.14
$10.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
94.2K
663.0K
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
1.35
Revenue
N/A
$106,470,000.00
Revenue This Year
$9.02
$37.27
Revenue Next Year
$10.41
$53.42
P/E Ratio
N/A
$7.70
Revenue Growth
N/A
350.91
52 Week Low
$2.20
$6.85
52 Week High
$3.90
$13.16

Technical Indicators

Market Signals
Indicator
ZKH
ZVRA
Relative Strength Index (RSI) 49.96 68.59
Support Level $3.08 $10.69
Resistance Level $3.54 $11.19
Average True Range (ATR) 0.15 0.39
MACD 0.02 0.12
Stochastic Oscillator 75.68 91.29

Price Performance

Historical Comparison
ZKH
ZVRA

About ZKH ZKH Group Limited

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: